Cases & Deals

  • Home
  • Practices
  • Elaia and Bpifrance co-lead €20.7 million seed financing of Enodia Therapeutics

Share

Elaia and Bpifrance co-lead €20.7 million seed financing of Enodia Therapeutics

January 2026

Client(s) Elaia Partners and Bpifrance

Jones Day advised Elaia and Bpifrance in the €20.7 million seed financing of Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, co-led with Pfizer Ventures as part of the InnoBio investment strategy.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.